Clinical Significance of the Immunohistochemical Expression of Histone Deacetylases (HDACs)-2, -4, and -5 in Ovarian Adenocarcinomas.
Georgia LevidouDimitrios ArsenakisDimitrios I BolovisRoxanne MeyerCosima V M BruckerThomas PapadopoulosStamatios TheocharisPublished in: Biomedicines (2024)
These findings suggest a differential expression among HDAC-2, -4, and -5 in ovarian adenocarcinomas in terms of immunolocalization, positivity rate, and associations with clinicopathological parameters, providing evidence for a potential role in the pathobiology of EOC.